A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Clinical trial NCT07105488 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07105488
Sponsor: Bluefin Biomedicine, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2025-07-15
Primary completion: 2027-02-28
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.